NEW YORK - The second of three bellwether trials scheduled in the federal Fosamax multidistrict litigation was dismissed on summary judgment on Nov. 23 after the judge found that two treating physicians were not qualified to testify as causation experts (In Re: Fosamax Products Liability Litigation, MDL Docket No. 1789, No. 06-md-1789, Bessie Flemings v. Merck & Co., Inc., No. 06-7631, S.D. N.Y.). From Mealey's Emerging Drugs & Devices

NEW BRUNSWICK, N.J. - The judge overseeing New Jersey's Aredia/Zometa litigation on Nov. 23 decided to apply New Jersey's limited punitive damage law in two cases brought by out-of-state plaintiffs (In Re: Aredia and Zometa, No. 278, Walter Bagley v. Novartis Pharmaceuticals Corp., No. L-6027-08MT, and Beverly Meng v. Novartis Pharmaceuticals Corp., No. L-7670-07MT, N.J. Super., Middlesex Co.). From Mealey's Emerging Drugs & Devices